246 related articles for article (PubMed ID: 19092668)
1. Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells.
Schaefermeier PK; Cabeza N; Besser JC; Lohse P; Daebritz SH; Schmitz C; Reichart B; Sodian R
ASAIO J; 2009; 55(1):86-92. PubMed ID: 19092668
[TBL] [Abstract][Full Text] [Related]
2. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
[TBL] [Abstract][Full Text] [Related]
4. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
5. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
[TBL] [Abstract][Full Text] [Related]
6. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
7. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
Weber B; Zeisberger SM; Hoerstrup SP
Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
[TBL] [Abstract][Full Text] [Related]
8. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
9. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering.
Taylor PM; Allen SP; Dreger SA; Yacoub MH
J Heart Valve Dis; 2002 May; 11(3):298-306; discussion 306-7. PubMed ID: 12056719
[TBL] [Abstract][Full Text] [Related]
10. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves.
Schenke-Layland K; Riemann I; Opitz F; König K; Halbhuber KJ; Stock UA
Matrix Biol; 2004 May; 23(2):113-25. PubMed ID: 15246110
[TBL] [Abstract][Full Text] [Related]
12. Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering.
Schmidt D; Achermann J; Odermatt B; Genoni M; Zund G; Hoerstrup SP
J Heart Valve Dis; 2008 Jul; 17(4):446-55; discussion 455. PubMed ID: 18751475
[TBL] [Abstract][Full Text] [Related]
13. From stem cells to viable autologous semilunar heart valve.
Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
[TBL] [Abstract][Full Text] [Related]
14. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves.
Tudorache I; Cebotari S; Sturz G; Kirsch L; Hurschler C; Hilfiker A; Haverich A; Lichtenberg A
J Heart Valve Dis; 2007 Sep; 16(5):567-73; discussion 574. PubMed ID: 17944130
[TBL] [Abstract][Full Text] [Related]
15. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
Leyh R; Wilhelmi M; Haverich A; Mertsching H
Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
[TBL] [Abstract][Full Text] [Related]
16. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells.
Rieder E; Seebacher G; Kasimir MT; Eichmair E; Winter B; Dekan B; Wolner E; Simon P; Weigel G
Circulation; 2005 May; 111(21):2792-7. PubMed ID: 15911701
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of interstitial cells isolated from human heart valves.
Roy A; Brand NJ; Yacoub MH
J Heart Valve Dis; 2000 May; 9(3):459-64; discussion 464-5. PubMed ID: 10888106
[TBL] [Abstract][Full Text] [Related]
18. Heart valve tissue engineering.
Neuenschwander S; Hoerstrup SP
Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
[TBL] [Abstract][Full Text] [Related]
19. The effect of cholecyst-derived extracellular matrix on the phenotypic behaviour of valvular endothelial and valvular interstitial cells.
Brody S; McMahon J; Yao L; O'Brien M; Dockery P; Pandit A
Biomaterials; 2007 Mar; 28(8):1461-9. PubMed ID: 17174391
[TBL] [Abstract][Full Text] [Related]
20. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
